Cell Biology Newsroom

 

Two School of Medicine faculty members have been honored with Presidential Early Career Awards for Scientists and Engineers (PECASE), the highest honor bestowed by the United States government on outstanding scientists and engineers early in their careers.

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies.

Akankshi Munjal, PhD, assistant professor of cell biology, is driven by her fascination with watching development happen.

A team led by Rohit Singh, PhD, has developed a computational technique that allows large language models to predict antibody structures more accurately. The work, which could aid in finding new treatments for infectious diseases, is published in the journal Proceedings of the National Academy of Sciences.

The Duke University Office of Research and Innovation has awarded nearly $2 million in seed grants to jumpstart new research ideas. Department of Cell Biology faculty member Amy Gladfelter, PhD, was one of the recipients, for her work to understand how pathogenic fungi adapt to temperature stress.

Twenty-three of the citation laureates are Duke scholars or had a Duke affiliation when the landmark works were created over the last decade.

Victoria Deneke, Postdoctoral Scholar at Research Institute of Molecular Pathology (IMP), was a graduate student in Stefano Di Talia's lab in Cell Biology. Victoria is a lead author on a paper published in Cell on October 17, 2024 and highlighted in the New York Times and Nature.